Introduced in 2011, our cloud software brings together social messaging, data and workflows in a unified system of record, intelligence and action.
We are a leading technology-as-a-service platform for financial institutions in China.
9.75% Series D Cumulative Redeemable Perpetual Preferred Stock
BioVie Inc. (OTCQB: BIVI; up-listing to NASDAQ) Approximately $15,000,000 of units, with each unit consisting of one share of Class A common stock and one-half (1/2) of one warrant, each whole warrant exercisable for one share of common stock. After giving effect to the planned 1:125 reverse stock split. The final public offering price will be determined through negotiation between us and the lead underwriters in the offering and the recent market price used throughout this prospectus may not be indicative of the final offering price
Multimedia service provider based in Shenyang, China, with business relationships with national advertising clients.
We are a returns-focused company formed to pursue oil and natural gas mineral and royalty interest opportunities in leading oil-weighted onshore domestic resource plays.
Our goal is to become a diversified high-tech Internet company targeting fast growing technology sectors primarily in China. Our business segments primarily consist of online games and electric vehicles through our joint venture agreement with Faraday&Future Inc. or F&F.
We are a rapidly-growing online peer-to-peer lending marketplace facilitating loans between borrowers and investors, providing borrowers accessible, affordable credit and offering investors attractive risk-adjusted returns. From our inception through June 30, 2018, we have matched loan transactions with an aggregate value of approximately RMB4.99 billion ($743.53 million). We primarily conduct our businesses in Guangdong Province, China and service exclusively Chinese borrowers and investors.
We are a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates.
Annovis is a clinical stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease in Down syndrome (AD-DS), Alzheimer's disease (AD) and Parkinson's disease (PD).
We are a rapidly-growing manufacturer and distributor of environmentally-friendly, single-use disposable products primarily used in restaurants and foodservice settings. We supply a wide range of products for the foodservice industry, including food packaging, containers, tableware, cups, lids, cutlery and straws.
We are a late clinical-stage biopharmaceutical company focused on becoming the leader in identifying, developing and commercializing novel, non-opioid and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain.
Independent insurance distribution firm.
Progyny is a leading benefits management company specializing in fertility and family building benefits solutions in the United States.
We are a development stage precision gene therapy company dedicated to pioneering the development of targeted therapies based on our next-generation AAV vectors.
We are a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases.
We are a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases.
Youdao has developed and used technologies to provide learning content, applications and solutions to users of all ages
We are a biotechnology company committed to creating a new class of precision genetic medicines based on our proprietary base editing technology, with a vision of providing life-long cures to patients suffering from serious diseases.
We are an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on our patented Thin Film Freezing, or TFF, technology platform.
We are a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases.
We have built and operate an open end-to-end cloud robot system, and offer it as a service to the world.
We are a growth-oriented, independent oil and natural gas company focused on rapidly growing our reserves, production and cash flow through the acquisition, exploration, development and production of oil, natural gas, and natural gas liquids, or NGLs, reserves in the Permian Basin.
UPLISTING: We are FinTech company and payment facilitator (“PayFac”) that focuses on a suite of products in the merchant services and payment facilitator verticals and provides integrated business solutions to merchants throughout the United States.
Aesthetic medical service company.
We are a leading independent online insurance product and service platform in China that is not affiliated with insurance companies or other insurance industry participants.
We are a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.
FOLLOW-ON OFFERING: Nasdaq uplisting; VerifyMe, Inc. (“VerifyMe,” the “Company,” “we” or “us”) is a developmental stage technology solutions provider specializing in brand protection functions such as counterfeit prevention, authentication, serialization, track and trace features for labels, packaging and products.
We started Danke in 2015 to provide young people with comfortable yet affordable homes. Today, we are one of the largest co-living platforms in China with the fastest growth, according to iResearch.
We are a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.
Audio technology company.
We are a vertically integrated real estate finance company founded in 2004. We primarily originate and manage investor loans secured by 1-4 unit residential rental and small commercial properties, which we refer to collectively as investor real estate loans.
We are a biotechnology company focusing on early cancer screening and detection. We market and sell a multi-cancer screening and detection test that uses our innovative, patented cancer differentiation analysis, or CDA, technology and our proprietary cancer-detection device, or CDA device.
We are a pioneer and leader in China’s used car financing market, focusing on facilitating loans from financial institutions to prime borrowers in used car transactions.
We are a market-leading consumer products company with a presence in 95% of households across the United States.
We are a leading technology-driven platform in China’s chemical industry, connecting participants along the chemical value chain through our integrated solutions
We are an autonomous aerial vehicle technology platform company. We are pioneering the future of transportation through our proprietarily developed autonomous aerial vehicles, or AAVs, and related commercial solutions.
We are a leading provider of cloud-based software that simplifies, digitizes, and automates complex back-office financial operations for SMBs.
The Company is in the business of modifying cargo shipping containers and purpose-built modules for use in construction.
We are a clinical-stage biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious diseases, particularly those treated in hospital-based settings.
LMP, through its wholly owned subsidiaries, currently offers our customers the opportunity to buy, sell, rent and subscribe for, and obtain financing for automobiles both online and in person.
We are a clinical-stage oncology-focused biopharmaceutical company based in Singapore developing novel therapeutics for global markets.
A newly organized, diversified, closed-end management registered investment company with at least 80% of managed assets invested in equity securities and up to 20% in globally diversified income-producing securities. (see prospectus & brochure for complete strategy overview)
FOLLOW-ON OFFERING: Preferred stock. Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing pharmaceutical and biotechnology products and product candidates.
Engaged primarily in the design and development of ultra-efficient three-wheeled electric vehicles.